Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB)
about
Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complexPositively Selected Sites at HCMV gB Furin Processing Region and Their Effects in Cleavage Efficiency.Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B.Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropismHuman cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H.Glycoprotein H-related complexes of human cytomegalovirus: identification of a third protein in the gCIII complex.Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody.Cytomegalovirus strain diversity in seropositive women.Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodiesDistribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus.Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody responseDevelopment and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus.Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream.Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.Sequence requirements for proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne.Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination.
P2860
Q21089588-0EC21619-868E-408F-A42F-860AABF726C7Q33717651-F4AFBCDC-6212-4388-A6E8-E1A082F2DF5FQ33793463-AC3F1B56-B63B-4C89-B6DF-6FC96295AF5AQ34212879-FF8B75D0-6820-4588-B0A9-02FB503E7E26Q35847453-DFD0CA19-3CB7-4090-AC37-3950F1F6418CQ35881192-3BC73A69-1CB3-4E6A-B41C-499C6A6CDB26Q35946943-7D554C02-567F-4D94-9B00-37C7B7A5D386Q36084954-8EC7B5B3-8AF4-4EE2-91E0-03DC0951E134Q36497863-BA1C2957-F2E0-4B51-9AAE-28FC89CF0E0EQ36640712-6151969C-D214-4C46-AB63-48A32A8F12B5Q36687838-B8D18C3F-BEF4-4181-8D82-AB881ACC0071Q36780341-6EFC3C08-BA93-4C05-A967-69545EF9EE17Q36802016-EA7421D8-2B5B-4777-9F3B-D0A2C6869C76Q37347128-1E96DA8A-09C0-42B4-8319-51AF33CFB17CQ37479611-4AE5DDDF-603A-4CA9-8260-0F2FA2BF2326Q37563632-B960AB6E-F668-496C-A4DB-62F3154BC7E6Q40109322-73CC0E5D-E384-4786-A1C1-681258A237B2Q47115059-6E78B717-2C98-4E36-B27B-1379A45DFB10
P2860
Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB)
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Induction of complement-depend ...... cytomegalovirus gp55-116 (gB)
@en
type
label
Induction of complement-depend ...... cytomegalovirus gp55-116 (gB)
@en
prefLabel
Induction of complement-depend ...... cytomegalovirus gp55-116 (gB)
@en
P2093
P2860
P1433
P1476
Induction of complement-depend ...... cytomegalovirus gp55-116 (gB)
@en
P2093
P2860
P304
P407
P577
1988-09-01T00:00:00Z